Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery
Advances in the using in vitro transcribed (IVT) modRNA in the past two decades, especially the tremendous recent success of mRNA vaccines against SARS-CoV-2, have brought increased attention to IVT mRNA technology. Despite its well-known use in infectious disease vaccines, IVT modRNA technology is...
Main Authors: | Magdalena M. Żak, Lior Zangi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/10/1675 |
Similar Items
-
Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics
by: Sean C. Semple, et al.
Published: (2022-02-01) -
Cell-Specific mRNA Therapeutics for Cardiovascular Diseases and Regeneration
by: Raj Kishore, et al.
Published: (2024-01-01) -
Modified mRNA Formulation and Stability for Cardiac and Skeletal Muscle Delivery
by: Magdalena M. Żak, et al.
Published: (2023-08-01) -
mRNA in the Context of Protein Replacement Therapy
by: Theofanis Vavilis, et al.
Published: (2023-01-01) -
Lipid Nanoparticles Deliver the Therapeutic VEGFA mRNA In Vitro and In Vivo and Transform Extracellular Vesicles for Their Functional Extensions
by: Muhammad Nawaz, et al.
Published: (2023-04-01)